PONTIFEX MEDICAL ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2013
N/A
2014
N/A
2015
N/A
2016
2016/9
2017
2017/9
Bankruptcy risk for industry  1.1% 1.1% 1.1% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 0.0% 15.2% 10.8%  
Credit score (0-100)  0 0 0 16 24  
Credit rating  N/A N/A N/A BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 -0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2013
N/A
2014
N/A
2015
N/A
2016
2016/9
2017
2017/9

Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 0.0 -322 543  
EBITDA  0.0 0.0 0.0 -432 432  
EBIT  0.0 0.0 0.0 -462 402  
Pre-tax profit (PTP)  0.0 0.0 0.0 -494.5 366.8  
Net earnings  0.0 0.0 0.0 -390.0 282.3  
Pre-tax profit without non-rec. items  0.0 0.0 0.0 -494 367  

 
See the entire income statement

Balance sheet (kDKK) 
2013
N/A
2014
N/A
2015
N/A
2016
2016/9
2017
2017/9

Tangible assets total  0.0 0.0 0.0 105 75.3  
Shareholders equity total  0.0 0.0 0.0 -637 -355  
Interest-bearing liabilities  0.0 0.0 0.0 658 394  
Balance sheet total (assets)  0.0 0.0 0.0 642 470  

Net Debt  0.0 0.0 0.0 658 394  
 
See the entire balance sheet

Volume 
2013
N/A
2014
N/A
2015
N/A
2016
2016/9
2017
2017/9

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 0.0 -322 543  
Gross profit growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 0 642 470  
Balance sheet change%  0.0% 0.0% 0.0% 0.0% -26.8%  
Added value  0.0 0.0 0.0 -461.8 431.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 75 -59  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 0.0 -1.0 1.0  

Profitability 
2013
N/A
2014
N/A
2015
N/A
2016
2016/9
2017
2017/9
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 0.0% 143.5% 74.2%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 0.0% -36.1% 38.2%  
ROI %  0.0% 0.0% 0.0% -70.2% 76.5%  
ROE %  0.0% 0.0% 0.0% -60.7% 50.8%  

Solidity 
2013
N/A
2014
N/A
2015
N/A
2016
2016/9
2017
2017/9
Equity ratio %  0.0% 0.0% 0.0% -49.8% -43.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 0.0% -152.2% 91.3%  
Gearing %  0.0% 0.0% 0.0% -103.3% -111.1%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 9.9% 6.8%  

Liquidity 
2013
N/A
2014
N/A
2015
N/A
2016
2016/9
2017
2017/9
Quick Ratio  0.0 0.0 0.0 0.3 0.3  
Current Ratio  0.0 0.0 0.0 0.4 0.5  
Cash and cash equivalent  0.0 0.0 0.0 0.0 0.0  

Capital use efficiency 
2013
N/A
2014
N/A
2015
N/A
2016
2016/9
2017
2017/9
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 0.0 -741.9 -430.2  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2013
N/A
2014
N/A
2015
N/A
2016
2016/9
2017
2017/9
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0